Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Genetic polymorphism linked to heart attack risk:

This article was originally published in Clinica

Executive Summary

A Finnish team has found a genetic polymorphism that could lead to more than a three-fold increase in the risk of heart attack. Researchers at the University of Kuopio discovered that men with a polymorphism in a gene that codes for paraoxonase, an anti- oxidative enzyme in high density lipoproteins that protects against coronary disease, had over a three-fold risk of a first myocardial infarction compared with those who do not carry the polymorphism. The study appears in the August 21 edition of the British Medical Journal.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT079306

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel